RadNet, Inc.
RDNTAPI behind this page
RDNT Q1 2026 request
Playground key active
/api/financials?ticker=RDNT&year=2026&quarter=1
Pick an endpoint and run the request.
Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Revenue | 575,631 | 471,399 | +22.1% |
Show Product Lines breakouts |
|||
| Commercial insurance | 315,869 | 262,488 | +20.3% |
| Health Care Other | 24,804 | 12,543 | +97.8% |
| Health Care Patient Service | 545,218 | 439,349 | +24.1% |
| Management fee revenue | 7,481 | 6,279 | +19.1% |
| Medicaid | 13,991 | 11,690 | +19.7% |
| Medicare | 137,179 | 108,199 | +26.8% |
| Other payors | 33,590 | 27,691 | +21.3% |
| Revenue under capitation arrangements | 30,413 | 32,050 | -5.1% |
| Workers' compensation/personal injury | 12,304 | 10,459 | +17.6% |
Show Business Segments breakouts |
|||
| Digital health | 18,816 | 10,021 | +87.8% |
| Digital health · Intersegment Elimination | -10,305 | -9,200 | -12.0% |
| Digital health · Operating Segments | 29,121 | 19,221 | +51.5% |
| Imaging Center | 556,815 | 461,378 | +20.7% |
| Imaging Center · Operating Segments | 556,815 | 461,378 | +20.7% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -10,305 | -9,200 | -12.0% |
| Operating Segments | 585,936 | 480,599 | +21.9% |
| Operating Expenses Excluding Depreciation And Amortization | 550,512 | 453,480 | +21.4% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | 60,140 | 54,976 | +9.4% |
| Depreciation & Amortization | 44,967 | 35,483 | +26.7% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | 4,994 | 5,176 | -3.5% |
| Gain Loss On Disposition Of Assets | 2,591 | 402 | +544.5% |
| Severance Costs1 | 1,464 | 747 | +96.0% |
| Operating Expenses | 599,534 | 495,500 | +21.0% |
| Operating Income | -23,903 | -24,101 | +0.8% |
Show Business Segments breakouts |
|||
| Digital health · Operating Segments | -11,141 | -3,117 | -257.4% |
| Imaging Center · Operating Segments | 36,260 | 15,648 | +131.7% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 25,119 | 12,531 | +100.5% |
| Interest Expense Debt | 17,657 | 17,239 | +2.4% |
| Income Loss From Equity Method Investments | -3,825 | -2,599 | -47.2% |
| Other Non-Operating Income (Expense) | -4,907 | -7,712 | +36.4% |
| Non-Operating Income (Expense) | 8,925 | 9,034 | -1.2% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | 65 | 494 | -86.8% |
| Income Before Taxes | -32,828 | -33,135 | +0.9% |
| Income Tax Expense (Benefit) | 8,096 | 3,398 | +138.3% |
| Net Income | -24,732 | -29,737 | +16.8% |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | 8,734 | 8,189 | +6.7% |
| Parent | -33,466 | -37,926 | +11.8% |
| Retained Earnings | -33,466 | -37,926 | +11.8% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | 8,131 | 5,628 | +44.5% |
| Net Income Loss Attributable To Noncontrolling Interest | 8,734 | 8,189 | +6.7% |
| Net Income | -33,466 | -37,926 | +11.8% |
| EPS (Basic) | -0.43 | -0.51 | +15.7% |
| EPS (Diluted) | -0.43 | -0.51 | +15.7% |
| Wtd Avg Shares (Basic) | 77,057,835 | 74,382,356 | +3.6% |
| Wtd Avg Shares (Diluted) | 77,057,835 | 74,382,356 | +3.6% |
| Revenue (Q) | — | — | — |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | 73,330 | 66,274 | +10.6% |
| Interest Income | 5 | 7.7 | -35.1% |
| Comprehensive Income | -40,817 | -32,784 | -24.5% |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 455,339 | 717,323 | -36.5% |
| Accounts Receivable | 209,090 | 200,127 | +4.5% |
| Other Receivables Net Current (Q) | — | — | — |
Show Related Party Transactions By Related Party breakouts |
|||
| Affiliated Entity | 11,033 | 34,885 | -68.4% |
| Prepaid Expenses & Other Current Assets | 65,313 | 63,526 | +2.8% |
| Total Current Assets | 740,775 | 1,015,861 | -27.1% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | 85,217 | 66,970 | +27.2% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 862,057 | — | — |
| Operating Lease Right-of-Use Assets | 760,975 | 665,754 | +14.3% |
| Goodwill | 1,094,699 | — | — |
Show Business Segments breakouts |
|||
| Digital Health segment | 336,051 | — | — |
| Imaging Center | 758,648 | — | — |
Show Business Acquisition breakouts |
|||
| Business Acquisitions | 17,159 | — | — |
| Total Assets | 3,885,389 | 3,336,264 | +16.5% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 161 | 117.5 | +37.0% |
| Intangible Assets (Q) | — | — | — |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Certifications | 2,786 | — | — |
| Covenant not to compete and other contracts | 6,435 | 2,193 | +193.4% |
| Customer Relationships | 132,649 | 14,102 | +840.6% |
| Developed Technology & Software | 66,353 | 33,680 | +97.0% |
| Management service contracts | 12,961 | 15,249 | -15.0% |
| Others | 2,080 | — | — |
| Patent and trademarks | 1,377 | 1,531 | -10.1% |
| Trade Names | 10,460 | 301 | +3375.1% |
| Other Assets | |||
| Property Plant And Equipment Net Including Right Of Use Assets | 1,623,032 | 1,374,002 | +18.1% |
| Other Intangible Assets Net | 253,481 | 79,736 | +217.9% |
| Deferred Finance Costs Noncurrent Net | 1,538 | 2,120 | -27.5% |
| Investments In Affiliates Subsidiaries Associates And Joint Ventures | 131,409 | 110,803 | +18.6% |
| Deposits Assets | 40,455 | 36,262 | +11.6% |
| Current Liabilities | |||
| Accounts Payable And Accrued Liabilities Current | 454,602 | — | — |
| Other Liabilities Current (Q) | — | — | — |
Show Related Party Transactions By Related Party breakouts |
|||
| Affiliated Entity | 75,960 | 51,410 | +47.8% |
| Deferred Revenue (Current) | 11,975 | 3,416 | +250.6% |
| Operating Lease Liability Current | 66,591 | 57,896 | +15.0% |
| Notes Payable Current | 26,506 | 24,677 | +7.4% |
| Total Current Liabilities | 635,634 | 505,399 | +25.8% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | 12,271 | 45,309 | -72.9% |
| Current Portion of Long-Term Debt | 26,506 | — | — |
Show Long-Term Debt Type breakouts |
|||
| Commercial Paper | 8.6 | — | — |
| Non-Current Liabilities | |||
| Finance Lease Liability Noncurrent | 4,016 | — | — |
| Operating Lease Liabilities | 777,268 | 678,029 | +14.6% |
| Long Term Notes Payable | 1,059,977 | 985,454 | +7.6% |
| Deferred Tax Liabilities | 34,150 | 27,555 | +23.9% |
| Other Non-Current Liabilities | 21,632 | 3,310 | +553.5% |
| Total Liabilities | 2,532,677 | 2,199,747 | +15.1% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 41.4 | 31.5 | +31.4% |
| Long-Term Debt | 1,086,483 | 1,010,131 | +7.6% |
Show Debt Instrument breakouts |
|||
| Equipment notes payable at 3.6% to 7.2%, due through 2029, collateralized by medical equipment | 15,626 | 22,578 | -30.8% |
| First Lien Term Loan · Secured Debt | 958,680 | — | — |
| Restated Agreement [Member] · Secured Debt | 120,937 | — | — |
| Long-Term Debt | 1,059,977 | 985,454 | +7.6% |
| Stockholders' Equity | |||
| Common Stock | 8 | 7 | +14.3% |
| Additional Paid-In Capital | 1,211,912 | 1,016,762 | +19.2% |
| Accumulated Other Comprehensive Income | -2,466 | -3,919 | +37.1% |
| Retained Earnings | -128,903 | -114,711 | -12.4% |
| Total Stockholders' Equity | 1,080,551 | — | — |
| Minority Interest | 272,161 | 238,378 | +14.2% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 1,352,712 | 1,136,517 | +19.0% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -2,466 | -3,919 | +37.1% |
| Additional Paid In Capital | 1,211,912 | 1,016,762 | +19.2% |
| Common Stock | 8 | 7 | +14.3% |
| Noncontrolling Interest | 272,161 | 238,378 | +14.2% |
| Parent | 1,080,551 | 898,139 | +20.3% |
| Retained Earnings | -128,903 | -114,711 | -12.4% |
| Total Liabilities & Equity | 3,885,389 | 3,336,264 | +16.5% |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Operating Lease Right Of Use Asset Amortization Expense | 16,298 | 14,431 | +12.9% |
| Income Loss From Equity Method Investments Net Of Distributions | -1,069 | -2,599 | +58.9% |
| Amortization of Financing Costs | 779 | 728 | +7.0% |
| Stock-Based Compensation | 31,375 | 28,494 | +10.1% |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | -2,764 | — | — |
Show Business Acquisition breakouts |
|||
| CIMAR UK Limited | 937 | — | — |
| Kolb Radiology P.C. | 200 | — | — |
| See-Mode Technologies Pte. Ltd. | 1,627 | — | — |
| Change in Accounts Receivable | 9,375 | -14,306 | +165.5% |
| Increase Decrease In Other Current Assets | -6,172 | -7,206 | +14.3% |
| Increase Decrease In Other Noncurrent Assets | -660 | -1,691 | +61.0% |
| Increase Decrease In Deferred Income Taxes | -9,099 | 5,137 | -277.1% |
| Increase Decrease In Operating Lease Liability | -13,299 | -21,968 | +39.5% |
| Increase Decrease In Deferred Revenue | 234 | 128 | +82.8% |
| Increase Decrease In Accounts Payable And Accrued Liabilities | 31,148 | 25,658 | +21.4% |
| Net Cash from Operations | 78,972 | 41,481 | +90.4% |
| Investing Activities | |||
| Payments To Acquire Buildings | -304,151 | -3,794 | -7916.6% |
| Payments To Acquire Other Property Plant And Equipment | -69,932 | -48,833 | -43.2% |
| Proceeds From Sale Of Property Plant And Equipment | 277 | 23 | +1104.3% |
| Proceeds From Collection Of Notes Receivable | 2,833 | — | — |
| Net Cash from Investing | -370,973 | -56,751 | -553.7% |
| Financing Activities | |||
| Principal Repayments On Notes And Leases Payable | -9,953 | -1,718 | -479.3% |
| Repayments Of Secured Debt | -5,252 | -5,000 | -5.0% |
| Payments To Minority Shareholders | -2,402 | -913 | -163.1% |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 103 | 121 | -14.9% |
| Net Cash from Financing | -17,504 | -7,510 | -133.1% |
| Supplemental | |||
| Interest Paid | 17,073 | 18,010 | -5.2% |
| Income Taxes Paid | 519 | 272 | +90.8% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -2,371 | 83 | -2956.6% |
| Net Change in Cash | -311,876 | -22,697 | -1274.1% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 455,339 | 717,323 | -36.5% |
Values in thousands USD. Source: SEC EDGAR 10-Q filing.